Navigation Links
Reportlinker Adds Global Analgesics Industry
Date:11/16/2010

ed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

corresponding Graph/Chart) 100

Table 56: German Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) 101

Table 57: German 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Others) and External Analgesics Markets for2005,2010 &

2015(includes corresponding Graph/Chart) 102

16c. ITALY 103

A.Market Analysis 103

Current and Future Analysis 103

Competitive Scenario 103

Table 58: Analgesics Market in Italy (2005): Market Share

of Leading Players by Value - Bayer Group, Angelini,

Novartis, Bristol-Myers Squibb, and Others (includes

corresponding Graph/Chart) 103

B.Market Analytics 104

Table 59: Italian Recent Past, Current & Future Analysis for

Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

corresponding Graph/Chart) 104

Table 60: Italian Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) 105

Table 61: Italian 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Reportlinker Adds Top Ten Worlds Leading Pharmaceutical Companies
2. Reportlinker Adds Top Ten Worlds Leading Life Science Intermediates Companies
3. Reportlinker Adds Global Blood Glucose Meters and Strips Industry
4. Reportlinker Adds Global Ambulatory & Bathroom Aids Industry
5. Reportlinker Adds Global Insulin Pumps (External) Industry
6. Reportlinker Adds Global Antibiotics Industry
7. Reportlinker Adds Global Medical Specialty Bags Industry
8. Reportlinker Adds Global Ophthalmic Instrumentation Industry
9. Reportlinker Adds Global Nuclear Medicine Industry
10. Reportlinker Adds U.S. Inflammatory Diseases Drug Delivery: Physician Perspective
11. Reportlinker Adds Proteomics - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , Mar. 30, 2015 Research and ... the addition of the "Medical Device Studies: ... This course has been designed specifically for ... required for medical devices and in-vitro diagnostic products. ... and the emphasis on high quality, appropriate clinical ...
(Date:4/1/2015)...  Egalet Corporation (Nasdaq: EGLT ) ("Egalet"), ... developing, manufacturing and marketing innovative pain treatments, today ... million aggregate principal amount of its convertible senior ... placement to qualified institutional buyers pursuant to Rule ... amended (the "Act"). Egalet also granted the initial ...
(Date:4/1/2015)... 1, 2015  Salix Pharmaceuticals, Ltd. ("Salix"), a ... (NYSE: VRX ) (TSX:VRX), today announced that ... aggregate principal amount of its 6.00% Senior Notes ... Notes ") pursuant to two redemptions. On May ... amount of the Notes, and on May 4, ...
Breaking Medicine Technology:Medical Device Studies: Clinical Evidence Seminar - London, UK, 13th, 14th of May 2015 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 7Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 2Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 3
... OMAHA, Neb., March 14, 2011 Transgenomic, Inc. ... announced the completion of an expanded license with the ... at Lower Denaturing temperature PCR) technology. Previously, Transgenomic had ... mitochondrial DNA analysis. The new license expands the technology ...
... OrbusNeich today announced the launch of the ... Stent combines the proven stent design of its ... a delivery system with enhanced crossability and flexible ... Helix stent design, offering conformability and radial strength ...
Cached Medicine Technology:Transgenomic Expands COLD-PCR License 2Transgenomic Expands COLD-PCR License 3Transgenomic Expands COLD-PCR License 4OrbusNeich Announces Availability of Azule™ Cobalt Chromium Stent 2
(Date:4/1/2015)... (PRWEB) April 01, 2015 GrassrootsHealth, ... announcing two continuing medical education (CME) courses about ... help practitioners become more confident in measuring, prescribing, ... After completion of these CME courses, practitioners can ... The CME courses available are “Vitamin D, Sunshine, ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 South Florida’s ... Provisional Certificate of Authority (PCOA) approval from the State ... in the ongoing development of a retirement community that ... health, wellness and spiritual development. , America’s aging population ... meet the housing needs of seniors, according to a ...
(Date:4/1/2015)... FL (PRWEB) April 01, 2015 IQ ... growing health and nutritional supplement companies in the U.S., today ... the testing and quality control standards for its herbal supplements.* ... the supply chain to ensure the accuracy of labeling on ... industry veteran and IQ Formulations CEO Jay Cohen ...
(Date:4/1/2015)... Dr. Rod J. Rohrich , ... the Department of Plastic Surgery at UT Southwestern Medical ... of blindness resulting from the use of facial ... their study, along with ideas for treatment and prevention ... began to see increasing reports of blindness as a ...
(Date:4/1/2015)... Texas (PRWEB) April 01, 2015 Senior ... Best of Home Care Provider of Choice Award by Home ... Choice Award is given to home care providers who ... providers are best-in-class for quality in home care. This recognition ... your satisfaction and will provide you with quality, trustworthy in ...
Breaking Medicine News(10 mins):Health News:GrassrootsHealth Launches CME Courses about Vitamin D 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 3Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3Health News:Senior Helpers of Central Texas Awarded Prestigious 2015 Senior Home Care Provider of Choice Award from Home Care Pulse 2
... cancer patients earlier by looking more carefully at CT ... regularly done to determine the extent or stage of ... radiologists at the University College Hospital in Galway, Ireland. ... if left untreated. The study focused on pulmonary embolism ...
... States with undiagnosed diabetes has declined sharply over the past ... than whites to unknowingly have the disease, according to a ... Smith found that in 1999-2002 about 20 percent of American ... disease, in contrast to 25 years ago when about half ...
... a study to be published in the Aug. 21 ... Cardiology, investigators at UT Southwestern Medical Center found that ... increased risk for heart disease. The research evaluates the ... of arterial disease. ,Our study shows that people who ...
... A drug increasingly used to prevent cluster headaches can ... the August 14, 2007, issue of Neurology, the medical ... the drug verapamil for cluster headaches should be closely ... irregular heartbeats. , Cluster headache is a rare, severe ...
... A newly developed DNA vaccine appears safe and may ... of individuals with multiple sclerosis, according to an article ... 2007 print issue of Archives of Neurology, one of ... (MS), the immune system attacks the myelin sheaths that ...
... 13, 2007, Paying out certain types of government aid in ... harmful and often fatal drug binges, according to a new ... Economics that links the monthly arrival of disability checks with ... findings by researchers at the University of California, Santa Cruz ...
Cached Medicine News:Health News:RAND finds cases of undiagnosed diabetes drop sharply 2Health News:RAND finds cases of undiagnosed diabetes drop sharply 3Health News:Waist-to-hip ratio may better predict cardiovascular risk than body mass index 2Health News:Drug for cluster headaches may cause heart problems 2Health News:DNA vaccine against multiple sclerosis appears safe, potentially beneficial 2Health News:Disability payments may spur drug abuse 2
Indications For Usage:, ,Single use on tracheostomy patients who can breathe spontaneously. The product is intended to be replaced at least once every 24 hours....
... provide protection to the exposed airway of the ... making it ideal for active young children as ... heat and moisture recovery, it ensures patient comfort ... filters have ISO standard tapered ends to assure ...
... helps provide protection to the exposed airway of ... lightweight making it ideal for active young children ... of heat and moisture recovery, it ensures patient ... and filters have ISO standard tapered ends to ...
For use with: , pulmonary function testing , nebulizer compressors , humidifiers , concentrators , proximal pressure lines ...
Medicine Products: